AW
BSX icon

Alaethes Wealth’s Boston Scientific BSX Stock Holding History

Alaethes Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
16,138
+382
+2% +$30.6K 0.29% 79
2025
Q4 		$1.5M Sell
15,756
-29
-0.2% -$2.84K 0.42% 74
2025
Q3 		$1.54M Buy
15,785
+1,704
+12% +$176K 0.44% 78
2025
Q2 		$1.51M Buy
+14,081
New +$1.42M 0.45% 75
2022
Q1 		– Sell
-38
Closed -$2K – 297
2021
Q4 		$2K Hold
38
– – ﹤0.01% 252
2021
Q3 		$2K Hold
38
– – ﹤0.01% 239
2021
Q2 		$2K Buy
+38
New +$1.6K ﹤0.01% 235

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alaethes Wealth's BSX Position: Q1 2026 in Review

Alaethes Wealth increased its Boston Scientific (BSX) stake by 2.4% in Q1 2026, buying an estimated $30.6K and bringing the position to 16,138 shares worth $1.01M. The position accounts for 0.29% of the portfolio, ranked #79.

Alaethes Wealth first reported a position in BSX in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.54M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Alaethes Wealth held 16,138 shares of Boston Scientific worth $1.01M as of Q1 2026.
  • Alaethes Wealth bought 382 Boston Scientific shares in Q1 2026, an estimated $30.6K.
  • Boston Scientific made up 0.29% of Alaethes Wealth's portfolio in Q1 2026, its #79 holding.
  • Alaethes Wealth first reported a position in Boston Scientific in Q2 2021 and has held it in 7 quarters since.
  • Alaethes Wealth's Boston Scientific position peaked at $1.54M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Alaethes Wealth's 13F filing for Q1 2026, filed 12 May 2026.